General Information of the Compound
Compound ID |
CP0035302
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(3Z)-3-(1H-pyrrol-2-ylmethylidene)-2,3-dihydro-1H-indol-2-one
Show/Hide
|
||||||||||||||||||
Synonyms |
(3Z)-3-(1H-pyrrol-2-ylmethylidene)-1H-indol-2-one
(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one
3-(1H-Pyrrol-2-ylmethylene)-1,3-dihydroindol-2-one
3-[(1H-Pyrrole-2-yl)methylene]-1H-indole-2(3H)-one
AC1NZGXV
BDBM17015
BRD-K51816706-001-01-7
CHEMBL86755
HSCI1_000049
Indolinone based inhibitor, 1
K00027
MolPort-023-197-743
NCGC00343760-01
Oxindole I
SCHEMBL1162655
SCHEMBL13819612
SEZFNTZQMWJIAI-FLIBITNWSA-N
Z-(1H-Pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one
ZINC3874586
oxindole 1
oxindole i
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C13H10N2O
|
||||||||||||||||||
Molecular Weight |
210.236
|
||||||||||||||||||
Canonical SMILES |
O=C1Nc2ccccc2\C1=C\c1ccc[nH]1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C13H10N2O/c16-13-11(8-9-4-3-7-14-9)10-5-1-2-6-12(10)15-13/h1-8,14H,(H,15,16)/b11-8-
Show/Hide
|
||||||||||||||||||
InChIKey |
SEZFNTZQMWJIAI-FLIBITNWSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound